EX-23.1 3 tm2522741d1_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

 

 

KPMG LLP

Suite 4000

1735 Market Street

Philadelphia, PA 19103-7501

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the use of our report dated March 21, 2025, with respect to the consolidated financial statements of TELA Bio, Inc. and subsidiaries, incorporated herein by reference.

 

/s/ KPMG LLP

 

Philadelphia, Pennsylvania

August 11, 2025